Nasal mucosa was sprayed with vasoconstrictor
xylometazoline 0.1%.
Before starting the measurement, Otrivine nasal spray (
Xylometazoline Hydrochloride 0.1% w/v, Zyma Healthcare) was used as a standard nasal decongestant.
Objective: To compare efficacy of chemical cautery with silver nitrate along with fucidin ointment versus topical vasoconstrictor spray (
xylometazoline 0.05%) and fucidin ointment application in idiopathic pediatric anterior epistaxis.
Airway preparation included instilling
xylometazoline 0.1% nasal drops in both nostrils 30 min prior to the procedure followed by nebulization with lignocaine 2% with adrenaline (1:200000) for 20 min supplemented with bilateral superior laryngeal nerve block and blocking the sensory input of recurrent laryngeal nerve by trans-tracheal block.
Previous therapy with local
xylometazoline, mometasone, and a combination of acrivastine and pseudoephedrine had little effect on the symptoms.
After local anesthesia of his naso- and oropharynx with aerosolized lidocaine (4%) and decongestant treatment of the nasal mucosa (
xylometazoline 1%), he received small incremental doses of sufentanil (total dose 35 [micro]g) for additional analgesia and light sedation during intubation.
A total of 50 patients who were selected for septoplasty were examined rhinomanometrically after decongestion by topical
xylometazoline. Each nostril was measured individually during quite inspiration.
Oral antibiotic prescribed was co-amoxiclav, vasoconstrictive nasal spray used was
Xylometazoline and local antibiotic ointment prescribed was fucidic acid ointment.
The mean of three approved PNIF measurements was recorded before and after decongestion with topical
xylometazoline (Otrivin[R] 1mg/ml, Novartis, Basel, Switzerland) with the subjects in a sitting position and the head held in a level position.
His previous medications oral cetirizine 10 mg/day in morning and hydroxyzine 25 mg/day in evening along with montelukast sodium 10 mg/day along with
xylometazoline nasal drops were continued.
The latest report also states that Novartis containing
Xylometazoline, could cause strophic rhinitis if not used as directed.